Clinical Trial Update: Deep Brain Stimulation (DBS) of the Nucleus Basalis Meynert (NBM) to Treat Cognitive Deficits in Light to Moderate Alzheimer's Disease [NA]

View source ↗

Summary

Clinical trial assessing deep brain stimulation of the nucleus basalis of Meynert to address cognitive deficits in light-to-moderate Alzheimer's disease has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: University of Cologne | Conditions: Alzheimer Disease | NA | Status: COMPLETED